POLICY BRIEFINGS


W&Ms Considers Negotiated Rulemaking Solution to Surprise Billing


Chairman of the House Ways and Means Committee Richard Neal (D-Mass.) has informed the panel’s Democratic members of a compromise he has offered to Ranking Member Kevin Brady (R-Texas) in their negotiations to protect patients from unexpected medical bills. According to his letter sent on September 27, Neal is proposing a negotiated rulemaking process to require stakeholders to work out their differences when payment disputes between providers and insurers for out-of-network care arise. He compares the structured process to that used in the Medicare clinical laboratory fee schedule and the durable medical equipment payment system. While the Chairman and Ranking Member agree that any framework from the Ways and Means Committee to address surprise bills will hold the patient harmless, Rep. Neal notes that he and the Ranking Member have “consistently encountered disagreement among stakeholders over reimbursement rates for out-of-network surprise bills and the extent to which a dispute resolution process can determine those rates.” The negotiated rulemaking process would require the U.S. departments of Health and Human Services (HHS), Labor, and Treasury and relevant stakeholders to form a committee to identify standards for payment rates for out-of-network care. This group would also determine how and whether to incorporate a dispute resolution process, while also ensuring that health care costs do not increase as a result. The committee’s recommendations would be finalized through notice and comment rulemaking. According to Rep. Neal, staff will work during the congressional recess to develop legislative language to be considered by the Committee during the next congressional work period.

In addition to the issue of surprise billing, Chairman Neal states that he expects the panel to address H.R. 3, the Lower Drug Costs Now Act, as well as bills to expand the Medicare benefit and address patient protections for individuals in hospice and nursing homes.


HHS to Fund Development of Two Filovirus Vaccines


The Biomedical Advanced Research and Development Authority (BARDA) announced that it will provide The Albert B. Sabin Vaccine Institute Inc. with technical expertise as well as $20.5 million in funding to simultaneously develop individual vaccine candidates against the Marburg virus and Sudan ebolavirus infections. Under the contract with the U.S. Department of Health and Human Services (HHS), the Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of each vaccine. BARDA will then have the choice to provide additional funding to move the candidates through Phase 2 clinical development.


FDA Warns of Device Cybersecurity Vulnerabilities


The Food and Drug Administration (FDA), alongside the U.S. Department of Homeland Security (DHS), has issued an urgent advisory warning to stakeholders about cybersecurity vulnerabilities that may be present in the operating systems of certain major medical devices. While the agency said that it is unaware of any adverse events resulting from the vulnerabilities, the risks may allow attackers to gain control of devices or hospital networks, cause denial of services, or leak information. The 11 possible defects originate with a software component used to communicate between computers known as IPNet. IPNet powers a range of medical devices worldwide. The problems may be considered non-critical or may require software patching. The affected manufacturing firms – including GE and Gräger – have issued warnings to their customers, but the FDA states that it expects additional devices with the vulnerabilities to be identified. The agency recommends that networks be monitored for intrusions and that doctors and patients discuss any potential risks. Health care facilities should use technologies such as firewalls and virtual private networks to reduce their risk of exposure, and manufacturers should report any devices identified as vulnerable to the Cybersecurity and Infrastructure Security Agency (CISA).


Celebration of National Penicillin Allergy Day Focused on Common Misperceptions


In recognition of National Penicillin Allergy Day on September 28, several key organizations, including the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the Infectious Diseases Society of America (IDSA), took the opportunity to better educate the public about correctly identifying individuals who are truly allergic to penicillin. Given that 9 out of 10 individuals who report a penicillin allergy are not actually allergic, it is important to correctly identify those who are allergic to ensure more appropriate prescribing of antibiotics, which helps combat the growth of antimicrobial resistance and the development of super bugs. The AAAAI recommends that penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. Recently, the Senate Appropriations FY20 Labor-HHS report language encouraged the U.S. Department of Health and Human Services “to educate the public and healthcare providers regarding the importance of penicillin allergy testing.” This education is part of a larger strategy, outlined by the Centers for Disease Control and Prevention (CDC) in its 2018 Update Antibiotic Use in the United States: Progress and Opportunities, where they cite that “Correctly identifying if patients are penicillin-allergic can decrease the unnecessary use of broad-spectrum antibiotics.” A congressional briefing on the topic is planned for the morning of November 1 in the Capitol Visitor Center.


POTUS Signs Autism CARES Act into Law


President Trump has signed the Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2019 (H.R. 1058) into law. The legislation would authorize $370 million annually through fiscal year (FY) 2024 for research, education, and intervention programs for individuals with autism spectrum disorder through the Interagency Autism Coordinating Committee. The bill will allow program participants to receive funding throughout their lifetimes, rather than being limited to their childhood years.


Grassley Continues Inquiry Into Genetic Testing


Senate Finance Committee Chairman Chuck Grassley has written to leadership at the U.S. Department of Health and Human Services (HHS) requesting information on what the Medicare program is doing to “detect and deter fraudulent genetic screening tests and protect beneficiaries from identity theft.” A recent fraud investigation by the Office of the Inspector General (OIG) uncovered potentially $2.1 billion in losses due to a scammer using offers of free tests to commit fraud. Sen. Grassley requests a response from Secretary Azar and Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma by October 16.



October 7, 2019: | Page 1 Page 2 Page 3

SERVICES




BRIEFING ARCHIVE


 -  2019


 +  2018